Position in ABBV
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,122,679,024
+$257,031,635 QoQ
Shares Held
4,461,449
+12.1% QoQ
Ownership
0.252%
of shares outstanding
% of Portfolio
1.62%
of 13F equity value
Holder Rank
#42
of 4,138 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FEDERATED HERMES, INC. holds $3,310,037,044 across 15 Drug Manufacturers - General names. ABBV ranks #1 (33.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
4,461,449 | $1,122,679,024 | |
| 2 | PFE |
Pfizer Inc
|
20,825,845 | $501,486,346 | |
| 3 | AMGN |
Amgen Inc
|
1,372,553 | $497,028,892 | |
| 4 | MRK |
Merck & Co., Inc.
|
2,852,266 | $366,516,180 | |
| 5 | LLY |
ELI LILLY & Co
|
255,206 | $306,101,756 | |
| 6 | JNJ |
Johnson & Johnson
|
732,891 | $186,132,326 | |
| 7 | SNY |
Sanofi
|
3,849,802 | $164,232,552 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
868,399 | $109,713,528 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,122,679,024 | 4,461,449 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $865,647,389 | 3,980,171 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $867,853,456 | 3,798,212 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $932,176,564 | 4,025,985 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $634,510,783 | 3,418,332 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $687,935,872 | 3,283,390 | Shares | Defined | 2025-05-08 | |
| 2024-12-31 | $456,142,038 | 2,566,922 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $369,145,214 | 1,869,279 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $312,255,759 | 1,820,521 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $325,560,746 | 1,787,813 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $355,292,435 | 2,292,653 | Shares | Defined | 2024-01-31 | |
| 2023-09-30 | $276,503,466 | 1,854,981 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $248,215,502 | 1,842,318 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $418,661,324 | 2,626,977 | Shares | Defined | 2023-05-08 | |
| 2022-12-31 | $429,255,551 | 2,656,120 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $325,859,194 | 2,427,980 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $400,032,170 | 2,611,858 | Shares | Defined | 2022-09-16 | |
| 2022-03-31 | $632,381,219 | 3,900,939 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $699,393,941 | 5,165,391 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $544,485,473 | 5,047,608 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $568,935,289 | 5,050,917 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $555,457,762 | 5,132,672 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $555,806,764 | 5,187,184 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $489,891,394 | 5,593,006 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $644,703,780 | 6,566,549 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $621,958,853 | 8,163,261 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||